Can Keeping Clinical Trial Participants Blind to Their Study Treatment Adversely Affect Subsequent Care?
Blader, Joseph C.
Contemporary Clinical Trials 2005 June; 26(3): 290-299
Showing items related by title, author, creator and subject.
Equitable Treatment for HIV/AIDS Clinical Trial Participants: A Focus Group Study of Patients, Clinical Researchers, and Administrators in Western Kenya Shaffer, D.N.; Yebei, V.N.; Ballidawa, J.B.; Sidle, J.E.; Greene, J.Y.; Meslin, E.M.; Kimaiyo, S.J.N.; Tierney, W.M. (2006-01)OBJECTIVES: To describe the concerns and priorities of key stakeholders in a developing country regarding ethical obligations held by researchers and perceptions of equity or "what is fair" for study participants in an ...
Subjects' Views of Obligations to Ensure Post-Trial Access to Drugs, Care and Information: Qualitative Results From the Experiences of Participants in Clinical Trials (EPIC) Study Sofaer, N.; Thiessen, C.; Goold, S.D.; Ballou, J.; Getz, K.A.; Koski, G.; Krueger, R.A.; Weissman, J.S. (2009-03)OBJECTIVES: To report the attitudes and opinions of subjects in US clinical trials about whether or not, and why, they should receive post-trial access (PTA) to the trial drug, care and information. DESIGN: Focus groups, ...
Attitudes Towards Clinical Research Among Cancer Trial Participants and Non-Participants: An Interview Study Using a Grounded Theory Approach Madsen, S.M.; Holm, S.; Riis, P. (2007-04)The attitudes of women patients with cancer were explored when they were invited to participate in one of three randomised trials that included chemotherapy at two university centres and a satellite centre. Fourteen patients ...